People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)
17 May 2019
Mr. John W. Childs serves as Director of the Company. Mr. Childs has been chairman and partner of J.W. Childs Associates, L.P., a private equity firm, since 1995. From 1991 to 1995, Mr. Childs was senior managing director of Thomas H. Lee Partners and from 1987 to 1990 was a managing director of Thomas H. Lee Partners. Prior to 1987, Mr. Childs was associated with the Prudential Insurance Company of America ("Prudential") for 17 years where he held various executive positions in the investment area, ultimately serving as senior managing director in charge of the Capital Markets Group at which time he was responsible for Prudential's approximately $77 billion fixed income portfolio, including all of the Capital Markets Group's investments in leveraged acquisitions. He is currently a director and chairman of the board of KB Wine Corporation, and serves as a director of KeyImpact Sales and Systems, Inc., Kleo Pharmaceuticals, Omax Health, J.W. Childs Asia Equities, This Realm, LLC, and SIMCOM, Inc. Mr. Childs holds a B.A. from Yale University and an M.B.A. from Columbia University. We believe that Mr. Childs' extensive operational and capital markets experience qualifies him to serve as a member of our Board.
|Total Annual Compensation, USD||--|
|Restricted Stock Award, USD||136,846|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||16,875|
|Fiscal Year Total, USD||153,721|